Skip to main content
Equibles

UBS Group AG

Position in NVCR — NovoCure Ltd

CIK 1610520 ZURICH, V8
Back to NVCR Full portfolio

Position in NVCR

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$2,679,404
+$759,055 QoQ
Shares Held
245,817
+65.5% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 98.16774267036047.ToString("F0")% Shared 0.ToString("F0")% None 1.8322573296395286.ToString("F0")%

Common Shares in NVCR Over Time

Shares Held

Position Value (USD)

Derivatives in NVCR

reported options exposure · as of Mar 31, 2026
CallValue
$479,600
CallShares
44,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

UBS Group AG holds $5,241,938,219 across 132 Medical Devices names. NVCR ranks #46 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,152,765 $1,247,724,380
2 BSX
Boston Scientific Corp
 14,824,662 $930,247,536
3 MDT
Medtronic plc
 6,412,252 $555,621,633
4 SYK
Stryker Corp
 1,646,714 $541,093,748
5 DXCM
Dexcom Inc
 4,349,959 $273,177,422
6 EW
Edwards Lifesciences Corp
 2,561,776 $205,147,019
7 GEHC
GE HealthCare Technologies Inc.
 2,805,315 $199,682,320
8 PEN
Penumbra Inc
 560,335 $183,997,200

All Filings in NVCR

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,679,404 245,817
2026-03-31 $479,600 44,000
2025-12-31 $1,920,349 148,519
2025-09-30 $1,059,116 81,975
2025-06-30 $4,866,199 273,382
2025-03-31 $3,626,370 203,500
2025-03-31 $7,191,064 403,539
2024-12-31 $5,960 200
2024-12-31 $15,618,446 524,109
2024-12-31 $6,845,060 229,700
2024-09-30 $3,126,000 200,000
2024-09-30 $3,126 200
2024-09-30 $2,422,179 154,970
2024-06-30 $7,035,598 410,718
2024-06-30 $4,584,450 267,627
2024-06-30 $3,426 200
2024-03-31 $171,930 11,000
2024-03-31 $5,402,726 345,664
2023-12-31 $2,148,427 143,900
2023-12-31 $252,376 16,904
2023-12-31 $576,298 38,600
2023-09-30 $670,225 41,500
2023-09-30 $2,323,985 143,900
2023-09-30 $76,082 4,711
2023-06-30 $1,722,250 41,500
2023-06-30 $442,763 10,669
2023-06-30 $3,577,300 86,200
2023-03-31 $4,041,408 67,200
2023-03-31 $861,443 14,324
2023-03-31 $577,344 9,600
2022-12-31 $1,065,408 14,525
2022-12-31 $2,956,005 40,300
2022-12-31 $674,820 9,200
2022-09-30 $752,428 9,903
2022-09-30 $562,252 7,400
2022-09-30 $699,016 9,200
2022-06-30 $639,400 9,200
2022-06-30 $514,300 7,400
2022-06-30 $481,982 6,935
2022-03-31 $613,090 7,400
2022-03-31 $762,220 9,200
2022-03-31 $735,706 8,880
2021-12-31 $690,736 9,200
2021-12-31 $873,630 11,636
2021-12-31 $555,592 7,400
2021-09-30 $859,658 7,400
2021-09-30 $1,068,764 9,200
2021-09-30 $1,123,014 9,667
2021-06-30 $5,545,500 25,000
2021-06-30 $11,091,000 50,000

Report a Problem

Category
Description
Email (optional, for follow-up)